If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.60    0.00 (0.00%)
Bid:
2.50
Ask:
2.70
Spread: 0.20 (8.00%)
Market Cap: £18.84m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Issue of Equity

12 Nov 2007 07:01

Amphion Innovations PLC12 November 2007 12 November 2007 Amphion Innovations plc Subscription of 2,272,728 New Ordinary Shares London and New York, 12 November 2007- Amphion Innovations plc (LSE: AMP)("Amphion" or the "Company"), the developer of medical and technologybusinesses, today announces that it has raised £500,000 (before expenses) by theissue of 2,272,728 new ordinary shares of 1p each in the capital of the Company(the "New Ordinary Shares") to an institutional investor by way of subscriptionat an issue price of 22 pence per New Ordinary Share to enable the Company toinvest in current and new Partner Companies and to provide working capital forthe Company. The New Ordinary Shares will represent approximately 1.8 per centof the existing Amphion share capital. Application will be made to the London Stock Exchange for the New OrdinaryShares to be admitted to trading on AIM. The New Ordinary Shares will, whenissued, rank equally in all respects with the existing Ordinary Shares,including the right to receive any dividend or other distribution declared, madeor paid following Admission. It is expected that Admission will becomeeffective and that dealings in the New Ordinary Shares will commence 15 November2007. Following admission of the New Ordinary Shares, the Company will have128,292,029 ordinary shares in issue with each ordinary share holding one votingright. For further information, please contact: Amphion Innovations plc +1 212 210 6224Charlie Morgan Financial Dynamics +44 20 7831 3113Ben AtwellSusan Quigley Charles Stanley Securities (Nominated Adviser) +44 20 7149 6000Mark TaylorFreddy Crossley About Amphion Innovations plcAmphion Innovations plc (LSE: AMP) builds shareholder value in high growthcompanies in the medical and technology sectors. Amphion uses a focused,hands-on company building approach based on decades of experience in both the USand UK. On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20267:00 amRNSNotice of AGM and proposed Board appointments
26th Jun 20267:00 amRNSAnnual Financial Report
17th Feb 20267:06 amRNSTR-1 NOTIFICATION OF MAJOR HOLDINGS
17th Feb 20267:00 amRNSUltimate Beneficial Owner Notification
19th Jan 20269:31 amRNSMey BESS planning
18th Dec 202511:34 amRNS-ROffshore works completed at MeyGen site
20th Nov 20257:00 amRNSCCR funding completed
10th Nov 202510:34 amRNS-RAmpeak Energy welcomes Cabinet Secretary to MeyGen
4th Nov 20257:00 amRNS-RAmpeak Energy Investor Day
13th Oct 20259:08 amRNSAW2 Battery Project receives formal planning
7th Oct 20257:00 amRNSAmpeak Energy Investor Day
1st Oct 202512:46 pmRNSAmpeak Energy achieves planning permission for AW2
30th Sep 202510:23 amRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSAmpeak Energy Interim Results
22nd Sep 202512:09 pmRNS-RAmpeak Energy hosts AW1 Groundbreaking Ceremony
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.